128 related articles for article (PubMed ID: 17446177)
1. Lumazine synthase from Candida albicans as an anti-fungal target enzyme: structural and biochemical basis for drug design.
Morgunova E; Saller S; Haase I; Cushman M; Bacher A; Fischer M; Ladenstein R
J Biol Chem; 2007 Jun; 282(23):17231-41. PubMed ID: 17446177
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of lumazine synthase from Mycobacterium tuberculosis as a target for rational drug design: binding mode of a new class of purinetrione inhibitors.
Morgunova E; Meining W; Illarionov B; Haase I; Jin G; Bacher A; Cushman M; Fischer M; Ladenstein R
Biochemistry; 2005 Mar; 44(8):2746-58. PubMed ID: 15723519
[TBL] [Abstract][Full Text] [Related]
3. Structural study and thermodynamic characterization of inhibitor binding to lumazine synthase from Bacillus anthracis.
Morgunova E; Illarionov B; Saller S; Popov A; Sambaiah T; Bacher A; Cushman M; Fischer M; Ladenstein R
Acta Crystallogr D Biol Crystallogr; 2010 Sep; 66(Pt 9):1001-11. PubMed ID: 20823551
[TBL] [Abstract][Full Text] [Related]
4. Catalysis product captured in lumazine synthase from the fungal pathogen Candida glabrata.
Shankar M; Wilbanks SM; Nakatani Y; Monk BC; Tyndall JD
Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1580-6. PubMed ID: 23897480
[TBL] [Abstract][Full Text] [Related]
5. Studies on the lumazine synthase/riboflavin synthase complex of Bacillus subtilis: crystal structure analysis of reconstituted, icosahedral beta-subunit capsids with bound substrate analogue inhibitor at 2.4 A resolution.
Ritsert K; Huber R; Turk D; Ladenstein R; Schmidt-Bäse K; Bacher A
J Mol Biol; 1995 Oct; 253(1):151-67. PubMed ID: 7473709
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure analysis of a pentameric fungal and an icosahedral plant lumazine synthase reveals the structural basis for differences in assembly.
Persson K; Schneider G; Jordan DB; Viitanen PV; Sandalova T
Protein Sci; 1999 Nov; 8(11):2355-65. PubMed ID: 10595538
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of an amide into 5-phosphonoalkyl-6-D-ribitylaminopyrimidinedione lumazine synthase inhibitors results in an unexpected reversal of selectivity for riboflavin synthase vs lumazine synthase.
Cushman M; Yang D; Mihalic JT; Chen J; Gerhardt S; Huber R; Fischer M; Kis K; Bacher A
J Org Chem; 2002 Oct; 67(20):6871-7. PubMed ID: 12353976
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of acyclic C-nucleoside and N-methylated derivatives of the ribitylaminopyrimidine substrate of lumazine synthase as potential enzyme inhibitors and mechanistic probes.
Chen J; Sambaiah T; Illarionov B; Fischer M; Bacher A; Cushman M
J Org Chem; 2004 Oct; 69(21):6996-7003. PubMed ID: 15471444
[TBL] [Abstract][Full Text] [Related]
9. A new series of 3-alkyl phosphate derivatives of 4,5,6,7-tetrahydro-1-D-ribityl-1H-pyrazolo[3,4-d]pyrimidinedione as inhibitors of lumazine synthase: design, synthesis, and evaluation.
Zhang Y; Jin G; Illarionov B; Bacher A; Fischer M; Cushman M
J Org Chem; 2007 Sep; 72(19):7176-84. PubMed ID: 17705537
[TBL] [Abstract][Full Text] [Related]
10. Structural and thermodynamic insights into the binding mode of five novel inhibitors of lumazine synthase from Mycobacterium tuberculosis.
Morgunova E; Illarionov B; Sambaiah T; Haase I; Bacher A; Cushman M; Fischer M; Ladenstein R
FEBS J; 2006 Oct; 273(20):4790-804. PubMed ID: 16984393
[TBL] [Abstract][Full Text] [Related]
11. Potential anti-infective targets in pathogenic yeasts: structure and properties of 3,4-dihydroxy-2-butanone 4-phosphate synthase of Candida albicans.
Echt S; Bauer S; Steinbacher S; Huber R; Bacher A; Fischer M
J Mol Biol; 2004 Aug; 341(4):1085-96. PubMed ID: 15328619
[TBL] [Abstract][Full Text] [Related]
12. X-ray structure analysis and crystallographic refinement of lumazine synthase from the hyperthermophile Aquifex aeolicus at 1.6 A resolution: determinants of thermostability revealed from structural comparisons.
Zhang X; Meining W; Fischer M; Bacher A; Ladenstein R
J Mol Biol; 2001 Mar; 306(5):1099-114. PubMed ID: 11237620
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of 9-D-ribitylamino-1,3,7,9-tetrahydro-2,6,8-purinetriones bearing alkyl phosphate and alpha,alpha-difluorophosphonate substituents as inhibitors of tiboflavin synthase and lumazine synthase.
Cushman M; Sambaiah T; Jin G; Illarionov B; Fischer M; Bacher A
J Org Chem; 2004 Feb; 69(3):601-12. PubMed ID: 14750781
[TBL] [Abstract][Full Text] [Related]
14. The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors.
Cutfield SM; Dodson EJ; Anderson BF; Moody PC; Marshall CJ; Sullivan PA; Cutfield JF
Structure; 1995 Nov; 3(11):1261-71. PubMed ID: 8591036
[TBL] [Abstract][Full Text] [Related]
15. Divergence in macromolecular assembly: X-ray crystallographic structure analysis of lumazine synthase from Brucella abortus.
Braden BC; Velikovsky CA; Cauerhff AA; Polikarpov I; Goldbaum FA
J Mol Biol; 2000 Apr; 297(5):1031-6. PubMed ID: 10764570
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and enzyme inhibitory activity of the s-nucleoside analogue of the ribitylaminopyrimidine substrate of lumazine synthase and product of riboflavin synthase.
Talukdar A; Illarionov B; Bacher A; Fischer M; Cushman M
J Org Chem; 2007 Sep; 72(19):7167-75. PubMed ID: 17696548
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of 6-carboxyalkyl and 6-phosphonoxyalkyl derivatives of 7-oxo-8-ribitylaminolumazines as inhibitors of riboflavin synthase and lumazine synthase.
Cushman M; Yang D; Gerhardt S; Huber R; Fischer M; Kis K; Bacher A
J Org Chem; 2002 Aug; 67(16):5807-16. PubMed ID: 12153285
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure analysis of icosahedral lumazine synthase from Salmonella typhimurium, an antibacterial drug target.
Kumar P; Singh M; Karthikeyan S
Acta Crystallogr D Biol Crystallogr; 2011 Feb; 67(Pt 2):131-9. PubMed ID: 21245535
[TBL] [Abstract][Full Text] [Related]
19. A structure-based model of the reaction catalyzed by lumazine synthase from Aquifex aeolicus.
Zhang X; Meining W; Cushman M; Haase I; Fischer M; Bacher A; Ladenstein R
J Mol Biol; 2003 Apr; 328(1):167-82. PubMed ID: 12684006
[TBL] [Abstract][Full Text] [Related]
20. Insights into the selective inhibition of Candida albicans secreted aspartyl protease: a docking analysis study.
Pranav Kumar SK; Kulkarni VM
Bioorg Med Chem; 2002 Apr; 10(4):1153-70. PubMed ID: 11836127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
